Small molecule p300/catenin antagonist enhances hematopoietic recovery after radiation

There is currently no FDA approved therapeutic agent for ARS mitigation post radiation exposure. Here we report that the small molecule YH250, which specifically antagonizes p300/catenin interaction, stimulates hematopoiesis in lethally or sublethally irradiated mice. A single administration of YH25...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yi, Wu, Kaijin, Nguyen, Cu, Smbatyan, Goar, Melendez, Elisabeth, Higuchi, Yusuke, Chen, Yibu, Kahn, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423697/
https://www.ncbi.nlm.nih.gov/pubmed/28486541
http://dx.doi.org/10.1371/journal.pone.0177245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423697/
https://www.ncbi.nlm.nih.gov/pubmed/28486541
http://dx.doi.org/10.1371/journal.pone.0177245

Ejemplares similares